ARCHIVES

Funding Opporunities: Program Announcments

This article is from The Cancer Letter archive.

Vol. 25 No. 02 | January 15, 1999

Download PDF Visit The Full Archive

Related Articles

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Gerald Murphy To Leave Cancer Society Sept. 1 To Direct Foundation

April 23, 1993

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

Benefit Of Chemotherapy Depends ER Status

April 28, 2006

Two “optimists” present different visions for rapid progress in cancer research at American Association for Cancer Research annual meeting. Leland Hartwell advocates genome-like project for molecular diagnostics. Andrew von Eschenbach describes “fantasies, dreams, visions” becoming reality.

April 9, 2004